Literature DB >> 22203087

Dopamine D4 and D5 receptor gene variant effects on clozapine response in schizophrenia: replication and exploration.

Rudi Hwang1, Arun K Tiwari, Clement C Zai, Daniel Felsky, Eli Remington, Tessa Wallace, Ryan P Tong, Renan P Souza, Gabriel Oh, Steven G Potkin, Jeffrey A Lieberman, Herbert Y Meltzer, James L Kennedy.   

Abstract

OBJECTIVES: This study aimed to: 1) replicate previously reported associations between dopamine D4 receptor gene (DRD4) polymorphisms and antipsychotic (AP) response in a clozapine (CLZ) response sample; and 2) explore possible associations of polymorphisms across dopamine D5 receptor gene (DRD5) as well as other DRD4 regions.
METHODS: DRD4 exon III 48-bp, intron I (G)(n), and 120-bp repeat polymorphisms, and three DRD4 single nucleotide polymorphisms (SNPs); and DRD5 (CA/CT/GT)(n) microsatellite and four DRD5 SNPs were assessed using standard genotyping and statistical procedures.
RESULTS: We report evidence, which does not survive correction for multiple testing, supporting previous DRD4 findings. Findings of interest include the 120-bp 1-copy allele, intron I (G)(n) 142-bp/140-bp genotype, and exon III 4R allele with CLZ response. All DRD5 tests were negative.
CONCLUSIONS: Overall, these results suggest a possible minor contribution of DRD4 variants, but not DRD5 variants, towards the AP/CLZ response phenotype. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22203087     DOI: 10.1016/j.pnpbp.2011.11.018

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  9 in total

1.  Exploring Biologic Predictors Response Disparities to Atypical Antipsychotics among Blacks: A Quasi-Systematic Review.

Authors:  Rebecca N Jerome; Jill M Pulley; Nila A Sathe; Shanthi Krishnaswami; Alyssa B Dickerson; Katherine J Worley; Consuelo H Wilkins
Journal:  Ethn Dis       Date:  2020-04-02       Impact factor: 1.847

Review 2.  Pharmacogenetics of Antipsychotic Drug Treatment: Update and Clinical Implications.

Authors:  Kazunari Yoshida; Daniel J Müller
Journal:  Mol Neuropsychiatry       Date:  2018-09-26

3.  Effect of thimerosal on the neurodevelopment of premature rats.

Authors:  Yan-Ni Chen; Jue Wang; Jie Zhang; Su-Jiao Li; Li He; Dong-Dong Shao; Hui-Ying Du
Journal:  World J Pediatr       Date:  2013-11-14       Impact factor: 2.764

4.  Combined clozapine and electroconvulsive therapy in a Japanese schizophrenia patient: a case report.

Authors:  Yuta Yoshino; Yuki Ozaki; Koichiro Kawasoe; Shinichiro Ochi; Takanori Niiya; Naomi Sonobe; Teruhisa Matsumoto; Shu-Ichi Ueno
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-08-12       Impact factor: 2.582

Review 5.  Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis.

Authors:  Shusuke Numata; Hidehiro Umehara; Tetsuro Ohmori; Ryota Hashimoto
Journal:  Front Pharmacol       Date:  2018-09-26       Impact factor: 5.810

6.  Biological Predictors of Clozapine Response: A Systematic Review.

Authors:  Ruta Samanaite; Amy Gillespie; Kyra-Verena Sendt; Grant McQueen; James H MacCabe; Alice Egerton
Journal:  Front Psychiatry       Date:  2018-07-26       Impact factor: 4.157

7.  Differential Effect of Dopamine D4 Receptor Activation on Low-Frequency Oscillations in the Prefrontal Cortex and Hippocampus May Bias the Bidirectional Prefrontal-Hippocampal Coupling.

Authors:  Carolina Wilnerzon Thörn; Vasilios Kafetzopoulos; Bernat Kocsis
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

Review 8.  Catechol-O-Methyltransferase Val158Met Polymorphism and Clinical Response to Antipsychotic Treatment in Schizophrenia and Schizo-Affective Disorder Patients: a Meta-Analysis.

Authors:  Eric Huang; Clement C Zai; Amanda Lisoway; Malgorzata Maciukiewicz; Daniel Felsky; Arun K Tiwari; Jeffrey R Bishop; Masashi Ikeda; Patricio Molero; Felipe Ortuno; Stefano Porcelli; Jerzy Samochowiec; Pawel Mierzejewski; Shugui Gao; Benedicto Crespo-Facorro; José M Pelayo-Terán; Harpreet Kaur; Ritushree Kukreti; Herbert Y Meltzer; Jeffrey A Lieberman; Steven G Potkin; Daniel J Müller; James L Kennedy
Journal:  Int J Neuropsychopharmacol       Date:  2016-04-29       Impact factor: 5.176

9.  Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics.

Authors:  Maria Koromina; Stefania Koutsilieri; George P Patrinos
Journal:  Hum Genomics       Date:  2020-01-15       Impact factor: 4.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.